Markets:

Overview

News

Currencies

International

Treasuries

IQVIA Holdings, Inc. Common Stock (NY:IQV)

192.76 +5.27 (+2.81%)

Streaming Delayed Price Updated: 3:17 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IQVIA Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

These S&P500 stocks are gapping in today's session ↗

April 09, 2025

Stay updated with the S&P500 gap up and gap down stocks on Wednesday. Get a glimpse of the market's movement during today's session.

Via Chartmill

What's going on in today's session: S&P500 gap up and gap down stocks ↗

March 31, 2025

Curious about the market action on Monday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

March 26, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest...

Via StockStory

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

March 25, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers.

Via StockStory

Earnings Scheduled For February 6, 2025 ↗

February 06, 2025

Via Benzinga

Analyst Expectations For IQVIA Hldgs's Future ↗

February 03, 2025

Via Benzinga

3 Reasons IQV is Risky and 1 Stock to Buy Instead

March 19, 2025

IQVIA’s stock price has taken a beating over the past six months, shedding 22.2% of its value and falling to $190.42 per share. This may have investors wondering how to approach the situation.

Via StockStory

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

March 18, 2025

Let’s dig into the relative performance of Fortrea (NASDAQ:FTRE) and its peers as we unravel the now-completed Q4 drug development inputs & services earnings season.

Via StockStory

10 Health Care Stocks Whale Activity In Today's Session ↗

March 11, 2025

Via Benzinga

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

March 11, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Repligen (NASDAQ:RGEN) and...

Via StockStory

IQVIA recognized as a leader in IDC MarketScape’s 2024 assessment for decentralized clinical trial technologies and consulting services

March 10, 2025

From IQVIA

Via Business Wire

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

March 05, 2025

Looking back on drug development inputs & services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

March 04, 2025

From IQVIA

Via Business Wire

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor ↗

February 25, 2025

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

Via Benzinga

IQVIA AI Assistant wins 2024 PM360 Innovation Award for Artificial Intelligence

February 24, 2025

From IQVIA

Via Business Wire

IQVIA CFO Ron Bruehlman to Speak at the TD Cowen Annual Health Care Conference on March 4, 2025

February 21, 2025

From IQVIA

Via Business Wire

IQVIA Releases 2024 Sustainability Report

February 20, 2025

From IQVIA

Via Business Wire

Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow

February 18, 2025

Lab services company Charles River Laboratories (NYSE:CRL) will be reporting earnings tomorrow before the bell. Here’s what investors should know.

Via StockStory

West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For

February 12, 2025

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings tomorrow morning. Here’s what to look for.

Via StockStory

Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect

February 09, 2025

Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours. Here’s what to expect.

Via StockStory

Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday? ↗

February 06, 2025

It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged...

Via Benzinga

Topics Stocks

IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions ↗

February 06, 2025

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and solid R&DS bookings fuel confidence.

Via Benzinga

Gapping S&P500 stocks in Thursday's session ↗

February 06, 2025

Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session.

Via Chartmill

Wondering what's happening in today's S&P500 pre-market session? ↗

February 06, 2025

Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.

Via Chartmill

IQVIA (NYSE:IQV) Exceeds Q4 Expectations, Stock Soars

February 06, 2025

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year revenue...

Via StockStory

IQVIA Reports Fourth-Quarter and Full-Year 2024 Results; Reaffirms Full-Year 2025 Guidance

February 06, 2025

From IQVIA Holdings Inc.

Via Business Wire

IQVIA (IQV) Q4 Earnings Report Preview: What To Look For

February 05, 2025

Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to look for.

Via StockStory

IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year

February 04, 2025

From IQVIA

Via Business Wire

IQVIA to Announce Fourth-Quarter and Full-Year 2024 Results on February 6, 2025

January 21, 2025

From IQVIA

Via Business Wire

Nvidia Eyes $1 Billion In Healthcare AI Revenue: Is This The Next Growth Frontier? ↗

January 14, 2025

Nvidia is making an ambitious leap into leveraging AI and accelerated computing to transform healthcare solutions.

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.